ABBV vs HXL · P/E 81, rev $16.99B vs P/E 59, rev $529.3M
AbbVie Inc (ABBV) versus Hexcel Corporation (HXL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Hexcel Corporation (HXL) is a aerospace & defense company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported HXL revenue for 2026-06-30 was $529.3M. Net income was $49.3M. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
Not investment advice. Open the ABBV and HXL stock pages for the full models.
Not investment advice.